Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 65.52% | 8.04% | 67.79% | 130.59% | 53.32% |
| Depreciation & Amortization | 2.23% | 2.32% | 1.61% | 1.07% | 0.18% |
| Other Operating Expenses | 25.61% | 134.68% | 177.64% | 213.93% | 150.00% |
| Total Operating Expenses | 53.57% | 26.54% | 9.50% | 15.44% | -8.96% |
| Operating Income | -52.50% | -25.60% | -8.82% | -15.25% | 8.96% |
| Income Before Tax | 38.23% | 41.59% | -4,125.96% | -790.95% | -449.07% |
| Income Tax Expenses | -7,918.18% | -7,918.18% | -- | -- | -- |
| Earnings from Continuing Operations | 48.61% | 52.09% | -4,128.96% | -791.71% | -449.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.35% | -48.39% | -25.40% | -33.33% | -61.46% |
| Net Income | 48.60% | 52.10% | -3,906.29% | -805.70% | -460.79% |
| EBIT | -52.50% | -25.60% | -8.82% | -15.25% | 8.96% |
| EBITDA | -68.60% | 7.93% | 14.57% | -15.18% | 9.00% |
| EPS Basic | 42.17% | 38.08% | -2,742.90% | -1,242.26% | -1,180.85% |
| Normalized Basic EPS | -4,755.49% | -3,702.52% | -1,170.28% | -339.91% | 116.56% |
| EPS Diluted | 49.32% | 45.54% | -2,022.83% | -1,292.89% | -1,231.54% |
| Normalized Diluted EPS | -355.80% | -403.76% | -835.85% | -468.73% | -69.09% |
| Average Basic Shares Outstanding | 392.37% | 193.42% | -21.41% | -60.61% | -75.03% |
| Average Diluted Shares Outstanding | 110.22% | 21.93% | -60.54% | -10.20% | -41.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |